| 5 | 1/1 | 返回列表 |
| 查看: 680 | 回復(fù): 2 | ||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | ||
txalex木蟲 (正式寫手)
|
[求助]
硫酸氫氯吡格雷制劑專利問(wèn)題
|
|
|
最近開始接手這個(gè)項(xiàng)目,有關(guān)專利問(wèn)題還不是很確定:現(xiàn)在歐盟那邊有一篇制劑專利,國(guó)內(nèi)也有一篇。我對(duì)于這兩篇專利具體保護(hù)的內(nèi)容有些拿不準(zhǔn),求高手幫忙。 這幾篇專利在第一條主權(quán)利要求中都列舉了處方中用到的一些輔料并且全部對(duì)其使用量進(jìn)行了限制,我想問(wèn)下我是不是就不可以使用該專利里列舉的輔料?還是我可以使用但是不能完全按照專利里面的輔料種類和用量來(lái)使用?有一點(diǎn)差別就可以了? 以下為歐盟專利的前幾條: Summary of the Invention [0007] One general aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose; stearic acid; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0008] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose and microcrystalline cellulose; stearic acid; and one or more of other pharmaceutically acceptable excipients wherein clopidogrel salt is hydrobromide or hydrochloride. [0009] Yet another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose; stearic acid and hydrogenated castor oil; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0010] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt; lactose and microcrystalline cellulose; stearic acid and hydrogenated castor oil; and one or more of other pharmaceutically acceptable excipients; wherein clopidogrel salt is hydrobromide or hydrochloride. [0011] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with the one or more of the diluents and other pharmaceutically acceptable excipients; (b) mixing one or more of the lubricants with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; wherein the clopidogrel salt is hydrobromide or hydrochloride. [0012] A further aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with lactose and other pharmaceutically acceptable excipients; (b) mixing stearic acid with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; wherein the clopidogrel salt is hydrobromide or hydrochloride. [0013] Another aspect, relates to a tablet of a clopidogrel salt comprising a therapeutically effective amount of a clopidogrel salt, prepared by process comprising the steps of (a) blending the clopidogrel salt with lactose and microcrystalline cellulose and optionally other pharmaceutically acceptable excipients; (b) mixing stearic acid with the blend of step (a); and (c) compressing the final blend of step (b) into tablet; |
金蟲 (正式寫手)

木蟲 (正式寫手)
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|